Video -

Attana Cell Biosensor

Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, the Attana Cell 200 minimizes costs and increases success during clinical trials. (produced by TTV AB)
go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.mp4
Length:
1:24
Download

Topics

  • Medical research

Categories

  • attana cell 200
  • attana
  • biosensor

Related media

Related content

Attana AB and Layerlab AB sign global distribution agreement

Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER ™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.

Tecan and Attana extend distribution agreement

Stockholm, Sweden, October 11, 2011- Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.

Fight against cancer - Attana's collaborator interviewed

Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

Attana's Story told by CEO and co-founder Dr. Teodor Aastrup

When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.

Find out: Why bridge the existing gap between biochemical and cell based assays?

One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

A New Generation of Cell-Biosensors targeting Cancer

Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation

Inspiration builds motivation

As any sports enthusiast knows, inspiration creates motivation for success. On a personal level, you don’t have to be inspired to get up at six in the morning to jog before work (you just need a desire to stay healthy), but if you are, you will not only notice that the sky is blue and the way the gravel crunches nicely under your shoes as you run; you will also look forward to...

Enter your email address to follow Attana AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Attana AB.

Okay